AMRX
Amneal Pharmaceuticals, Inc.
19.70$
+0.0%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.1% | 22.0% | -0.7% | 5.7% | 20.2% | 16.2% | 1.1% | 11.6% | 15.1% | 16.0% | -4.0% | -2.4% | 6.4% | |
| 9.2% | 9.2% | 8.4% | 9.0% | 8.4% | 9.1% | 8.7% | 8.3% | 6.9% | 6.0% | 6.0% | 6.0% | 6.2% | |
| 1.1% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.1% | 1.0% | 1.0% | 1.2% | 1.3% | 1.1% | |
| -5.6% | 8.7% | -1.8% | -16.6% | 6.1% | 3.0% | -15.3% | -4.8% | -6.5% | -1.5% | -26.3% | -24.1% | -14.3% | |
| 2.2% | 5.1% | 3.0% | 1.5% | 2.9% | 3.2% | 2.6% | 3.7% | 1.9% | 5.3% | 1.9% | 5.7% | 3.8% | |
| -2.2% | -5.1% | -3.0% | -0.9% | -2.9% | -2.2% | -2.6% | -3.7% | -2.9% | -5.6% | -3.0% | -15.4% | -6.8% | |
| 0.0% | 0.3% | -1.1% | 0.0% | 0.0% | -0.1% | -3.1% | 0.0% | – | – | – | – | – | |
| – | – | – | – | -12.4% | -7.6% | -2.5% | -2.1% | 17.9% | -0.8% | -0.9% | 11.8% | 7.1% | |
| -14.0% | -16.3% | -3.5% | -5.0% | -13.1% | -8.4% | -5.6% | -5.8% | 7.6% | -1.2% | -7.9% | 9.7% | 2.2% | |
| -3.1% | 0.6% | -7.2% | -0.3% | 4.1% | 5.5% | -7.2% | 2.1% | 19.7% | 9.2% | -15.1% | -8.2% | 1.8% | |
| 11.0% | 16.9% | -3.7% | 4.1% | 17.2% | 13.0% | -1.6% | 7.9% | 13.2% | 10.7% | -5.9% | -8.1% | 2.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.